Literature DB >> 4738906

Solid phase radioimmunoassay of properdin.

J O Minta, I Goodkofsky, I H Lepow.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4738906     DOI: 10.1016/0019-2791(73)90082-7

Source DB:  PubMed          Journal:  Immunochemistry        ISSN: 0019-2791


× No keyword cloud information.
  9 in total

1.  Resolution and analysis of 'native' and 'activated' properdin.

Authors:  T C Farries; J T Finch; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

2.  Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.

Authors:  M Takahashi; S Takahashi; V Brade; V Nussenzweig
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

3.  Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus.

Authors:  M A Schrager; N F Rothfield
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

4.  Glomerulonephritis with mesangial deposits of IgA unassociated with systemic disease.

Authors:  A Katz; B J Underdown; J O Minta; I H Lepow
Journal:  Can Med Assoc J       Date:  1976-02-07       Impact factor: 8.262

5.  Quantitative measurement of properdin in normal human serum by electroimmunoassay and single radial immunodiffusion.

Authors:  K Persson; C O Kindmark; J Pensky; G Naff
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

6.  Multiple sedimenting species of properdin in human serum and interaction of purified properdin with the third component of complement.

Authors:  J Chapitis; I H Lepow
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

7.  Properdin factor D. II. Activation to D by properdin.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

8.  Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.

Authors:  M Takahashi; B F Tack; V Nussenzweig
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

9.  The role of properdin in the alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.